Supplemental tables for Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab.

Name: Supplemental tables for Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab.
Published: 2025-06-24T13:03:26+00:00
License: https://creativecommons.org/publicdomain/mark/1.0/
Keywords: Lymphoid neoplasia

dataset

posted on 2025-06-24, 13:03 authored by Rui MuRui Mu, Katherine M. Hornick, Neelam Redekar, Jonathan Chen, Pia Nierman, Susan Soto, Rohan Herur, Clare Sun, Layla Saleh, Maissa Mhibik, Keyvan Keyvanfar, Inhye E. Ahn, Adrian Wiestner

Supplemental table 6; Supplemental table 10; Supplemental table 11; Supplemental table 12

Funding

This research was supported by the Intramural Research Program of the National Heart, Lung and Blood Institute (NHLBI) (HL006070-13 – NIH), and supported in part by a research grant from Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC.

Supplemental tables for Activation and exhaustion of CD8 T cells in patients with chronic lymphocytic leukemia treated with ibrutinib and pembrolizumab.

Funding

This research was supported by the Intramural Research Program of the National Heart, Lung and Blood Institute (NHLBI) (HL006070-13 – NIH), and supported in part by a research grant from Investigator-Initiated Studies Program of Merck Sharp & Dohme LLC.

History

Usage metrics

Categories

Keywords

Licence

Exports